Papers
6
Total Citations
146
H-Index
4
About
Dr. Xiaofeng Duan is a leading surgical oncologist whose research focuses on advancing the treatment of esophageal squamous cell carcinoma (ESCC) through minimally invasive techniques and innovative neoadjuvant strategies. His major contributions center on comparing and optimizing surgical approaches—specifically robot-assisted minimally invasive esophagectomy (RAMIE), video-assisted esophagectomy, and open surgery—to improve short-term outcomes for patients with locally advanced disease. Dr. Duan is particularly recognized for pioneering work in lymph node dissection around the left recurrent laryngeal nerve, a technically challenging procedure where he has demonstrated the advantages of robotic assistance, as evidenced by his study of over 400 patients. His most cited work, the Keystone-001 trial protocol (62 citations), explores the safety and effectiveness of combining pembrolizumab with chemotherapy as neoadjuvant therapy, representing a significant step toward integrating immunotherapy into surgical treatment pathways. With multiple comparative studies and a growing body of evidence, Dr. Duan’s research is shaping best practices in esophageal cancer surgery, offering patients less invasive options with potentially better recovery and oncologic outcomes.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6